Carter said the acquisition offers an “attractive entry price” for a portfolio of well-located assets in the U.K.’s “Golden Triangle,” with upside from leasing vacant space—much of it newly delivered—and capturing rental reversion. He added that British Land expects to generate “significant cost synergies from day one” by bringing the portfolio onto its operating platform and broadening the target tenant base beyond a life sciences-only mandate.Speaking on a webcast, CEO Simon Carter said the transaction st ...